68th Day Of Lockdown

Maharashtra65168280812197 Tamil Nadu2024611313157 Delhi173877846398 Gujarat1635692321007 Rajasthan83654855184 Madhya Pradesh78914444343 Uttar Pradesh77014651213 West Bengal48131775302 Andhra Pradesh3461228960 Bihar3359120915 Karnataka292299749 Telangana2499141277 Jammu and Kashmir234190828 Punjab2197194942 Odisha17239779 Haryana172194019 Kerala120957510 Assam9361044 Uttarakhand493794 Jharkhand4621914 Chhatisgarh4471021 Chandigarh2891994 Tripura2711720 Himachal Pradesh223634 Goa70420 Manipur6060 Puducherry57230 Nagaland3600 Meghalaya27121 Arunachal Pradesh310 Mizoram110 Sikkim100
Lifestyle Health and Wellbeing 09 Nov 2016 Weight loss can make ...

Weight loss can make immunotherapy for cancer patients ineffective

PTI
Published Nov 9, 2016, 8:04 pm IST
Updated Nov 9, 2016, 8:23 pm IST
Cancer immunotherapies involve activating a patients immune cells to recognise and destroy cancer cells.
The condition, known as cancer cachexia, causes loss of appetite (Photo: AP)
 The condition, known as cancer cachexia, causes loss of appetite (Photo: AP)

London: A weight loss condition that affects cancer patients may make immunotherapy ineffective, according to a new study which explains why the approach boosting a patients immune system to treat the disease fails in a lot of people.

Cancer immunotherapies involve activating a patients immune cells to recognise and destroy cancer cells.

 

They have shown great promise in some cancers, but so far have only been effective in a minority of patients with cancer. The reasons behind these limitations are not clear.

Researchers at the University of Cambridge have found evidence that the mechanism behind a weight loss condition which affects patients with cancer could also be making immunotherapies ineffective.

The condition, known as cancer cachexia, causes loss of appetite, weight loss and wasting in most patients with cancer towards the end of their lives.

However, cachexia often starts to affect patients with certain cancers, such as pancreatic cancer, much earlier in the course of their disease.

Scientists found that that even at the early stages of cancer development in mice, before cachexia is apparent, a protein released by the cancer changes the way the body, in particular the liver, processes its own nutrient stores.

"The consequences of this alteration are revealed at times of reduced food intake, where this messaging protein renders the liver incapable of generating sources of energy that the rest of the body can use," said Thomas Flint, from the University of Cambridge School of Clinical Medicine.

"This inability to generate energy sources triggers a second messaging process in the body - a hormonal response - that suppresses the immune cell reaction to cancers, and causes failure of anti-cancer immunotherapies," Flint said.

"Cancer immunotherapy might completely transform how we treat cancer in the future - if we can make it work for more patients," said Tobias Janowitz, from University of Cambridge.

"Our work suggests that a combination therapy that either involves correction of the metabolic abnormalities, or that targets the resulting hormonal response, may protect the patients immune system and help make effective immunotherapy a reality for more patients," said Janowitz.

"If the phenomenon that we have described helps us to divide patients into likely responders and non-responders to immunotherapy, then we can use those findings in early stage clinical trials to get better information on the use of new immunotherapies," said Duncan Jodrell, from the Cambridge Cancer Centre.

"Understanding the complicated biological processes at the heart of cancer is crucial for tackling the disease - and this study sheds light on why many cancer patients suffer from both loss of weight and appetite, and how their immune systems are affected by this process," said Nell Barrie, from Cancer Research UK.

The research was published in the journal Cell Metabolism.

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT